These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33650739)

  • 1. Preparation and characterization of leukocyte- and platelet-rich fibrin membrane derived from cats' blood.
    Castilho MS; Rahal SC; Dias Neto RDN; Pereira AC; Francia CCDA; Mesquita LDR; Antunes CB; Lainetti PF; Fonseca-Alves CE
    Microsc Res Tech; 2021 Aug; 84(8):1802-1808. PubMed ID: 33650739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
    Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M
    Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological, Immunohistochemical, Biomechanical, and Wettability Evaluations of the Leukocyte- and Platelet-Rich Fibrin Membranes Derived from Canine Blood.
    Graciani JCAOR; Rahal SC; Silva WM; Moroz I; Fonseca-Alves CE; Govoni VM; Kano WT
    J Vet Dent; 2023 Sep; 40(3):212-219. PubMed ID: 36726327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for harvesting concentrated platelet-rich fibrin (C-PRF) with a 10-fold increase in platelet and leukocyte yields.
    Miron RJ; Chai J; Zhang P; Li Y; Wang Y; Mourão CFAB; Sculean A; Fujioka Kobayashi M; Zhang Y
    Clin Oral Investig; 2020 Aug; 24(8):2819-2828. PubMed ID: 31788748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological comparison of Platelet rich fibrin clots prepared by fixed-angle versus horizontal centrifugation.
    Fujioka-Kobayashi M; Kono M; Katagiri H; Schaller B; Zhang Y; Sculean A; Miron RJ
    Platelets; 2021 Apr; 32(3):413-419. PubMed ID: 32306811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols.
    Fujioka-Kobayashi M; Katagiri H; Kono M; Schaller B; Zhang Y; Sculean A; Miron RJ
    Clin Oral Investig; 2020 Dec; 24(12):4373-4383. PubMed ID: 32382929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable platelet rich fibrin: cell content, morphological, and protein characterization.
    Varela HA; Souza JCM; Nascimento RM; Araújo RF; Vasconcelos RC; Cavalcante RS; Guedes PM; Araújo AA
    Clin Oral Investig; 2019 Mar; 23(3):1309-1318. PubMed ID: 30003342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Near-Infrared Imaging of Platelets in Platelet-Rich Fibrin (PRF) Matrices: Comparative Analysis of Bio-PRF, Leukocyte-Rich PRF, Advanced-PRF and Concentrated Growth Factors.
    Aizawa H; Tsujino T; Watanabe T; Isobe K; Kitamura Y; Sato A; Yamaguchi S; Okudera H; Okuda K; Kawase T
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin clot and Leukocyte-rich platelet-rich fibrin show similar release kinetics and amount of growth factors: a pilot study.
    Nakanishi Y; Matsushita T; Nagai K; Araki D; Hoshino Y; Kuroda R
    J Orthop Surg Res; 2023 Mar; 18(1):238. PubMed ID: 36964579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Bielecki T; Jimbo R; Barbé G; Del Corso M; Inchingolo F; Sammartino G
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1145-52. PubMed ID: 21740377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of platelets, transforming growth factor-β1, platelet-derived growth factor-BB, vascular endothelial growth factor and matrix metalloprotease-9 in advanced platelet-rich fibrin and concentrated growth factor matrices.
    Takahashi A; Tsujino T; Yamaguchi S; Isobe K; Watanabe T; Kitamura Y; Okuda K; Nakata K; Kawase T
    J Investig Clin Dent; 2019 Nov; 10(4):e12458. PubMed ID: 31461225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane.
    Dohan Ehrenfest DM; Del Corso M; Diss A; Mouhyi J; Charrier JB
    J Periodontol; 2010 Apr; 81(4):546-55. PubMed ID: 20373539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced platelet rich fibrin demonstrates improved osteogenic induction potential in human periodontal ligament cells, growth factor production and mechanical properties as compared to leukocyte and platelet fibrin and injectable platelet rich fibrin.
    Shah R; M G T; Thomas R; A B TK
    Oral Maxillofac Surg; 2024 Mar; 28(1):413-424. PubMed ID: 37269407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
    Schär MO; Diaz-Romero J; Kohl S; Zumstein MA; Nesic D
    Clin Orthop Relat Res; 2015 May; 473(5):1635-43. PubMed ID: 25690170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Leukocyte- and Platelet-Rich Fibrin on Central and Peripheral Nervous System Neurons-Implications for Biomaterial Applicability.
    Lambrichts I; Wolfs E; Bronckaers A; Gervois P; Vangansewinkel T
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation.
    Miron RJ; Chai J; Zheng S; Feng M; Sculean A; Zhang Y
    J Biomed Mater Res A; 2019 Oct; 107(10):2257-2271. PubMed ID: 31148358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characterization of an injectable platelet-rich fibrin mixture consisting of autologous albumin gel and liquid platelet-rich fibrin (Alb-PRF).
    Fujioka-Kobayashi M; Schaller B; Mourão CFAB; Zhang Y; Sculean A; Miron RJ
    Platelets; 2021 Jan; 32(1):74-81. PubMed ID: 31959025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Leukocyte- and Platelet-Rich Fibrin Block: Release of Growth Factors, Cellular Content, and Structure.
    Castro AB; Cortellini S; Temmerman A; Li X; Pinto N; Teughels W; Quirynen M
    Int J Oral Maxillofac Implants; 2019; 34(4):855–864. PubMed ID: 30742137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic Properties of 'Leukocyte- and Platelet-Rich Fibrin'.
    Ratajczak J; Vangansewinkel T; Gervois P; Merckx G; Hilkens P; Quirynen M; Lambrichts I; Bronckaers A
    Sci Rep; 2018 Oct; 8(1):14632. PubMed ID: 30279483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 24 protocols for the production of platelet-rich fibrin.
    Miron RJ; Chai J; Fujioka-Kobayashi M; Sculean A; Zhang Y
    BMC Oral Health; 2020 Nov; 20(1):310. PubMed ID: 33160335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.